IDIBAPS Virginia JC Garcia Pagan CIBERehd JHEP Reports 🆕 Un estudio coordinado por investigadores #CLÍNIC-IDIBAPS profundiza en la relación entre enfermedades hepáticas vasculares e infecciones virales crónicas. 🔗 Han revelado una conexión entre el trastorno vascular porto-sinusoidal y la #hepatitis B. 👉 i.mtr.cool/aewztfpysw

📣 Meet the ERN RARE LIVER team at our EASL booth from 6 to 8 June in Milan, Italy. 🇮🇹 ☀️ We would be happy to welcome as many members, partners and supporters as possible to our booth. For our activities check the programme: ➡️ tinyurl.com/4kz38ama

Meeting with community at EASLnews The Valdig Group Track Hub session was packed. Thank you Aurélie PLESSIER and Michael Praktiknjo for a great overview of the VALDIG activities 🎊👍

🆕The COST EURO-VALDI-NET has been accepted for funding‼️ Want to know more about this program aiming at favoring network activities on vascular liver diseases❓ ▶️ join the VALDIG general assembly meeting today Room Amber 5 #EASLCongress, 3PM cost.eu/60-new-actions…

Very interactive session with our endoscopists and radiologist colleagues on management of gastric variceal bleeding. Glue, TIPS, BRTO? No clear winner. More data needed CIBERehd Hospital Clínic IDIBAPS

Valdig Group General Assembly has started with chair Virginia EASLnews #easl2024

Rautou Pierre-Emmanuel talks about the #CostAction initiative. Great work for securing the funding! Valdig Group EASLnews Virginia

About to present EASL Education guidelines on vascular liver diseases #EASL2024 on behalf of a fantastic panel of experts‼️

Why portal hypertension develops in cirrhosis ? What are the clinical consequences ? Are there new targeted therapies in the horizon ? This great review by Jordi Gracia-Sancho et al. in The Lancet Gastroenterology & Hepatology explains it all. t.ly/JwdfD #livertwitter

Extraordinary talk by Dr Valentin Fuster at the closing of the ICCV sessions at the Hospital Clínic on the emerging need to combine new technologies and education. And the icing on the cake: the time dedicated to our resis and fellows. Eternally grateful😍 IDIBAPS marta sitges

📢🆕 Valdig Group study just out in HEPATOLOGY Journal Want to spare endoscopies in patients with PSVD❓ Spleen stiffness measurement < 40 kPa ➕ serum bilirubin < 1 mg/dL 🟰 < 5% of high risk varices ➡️ 21 to 38 % of endoscopies can be avoided journals.lww.com/hep/abstract/9…

It's out: The standard reference on 🩸portal vein thrombosis🩸 👉 diagnosis 👉 management 👉 endpoints for future clinical studies Chapeau Rautou Pierre-Emmanuel & team 🔗 authors.elsevier.com/c/1jO-d8nByrCi… #LiverTwitter The Lancet Gastroenterology & Hepatology

New Review - Elkrief et al - Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies thelancet.com/journals/langa… ERN RARE LIVER Valdig Group #LiverTwitter Rautou Pierre-Emmanuel

Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies Amazing collective work 💪 Everything there is to know, and more! + a new set of imaging criteria to play with ⬇️ thelancet.com/journals/langa… Valdig Group Rautou Pierre-Emmanuel

🟪NEW Article in press❕ Persistent Varices in Cured Patients: Understanding the role of Hepatic Venous Pressure Gradient 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-… #LiverTwitter Virginia JC Garcia Pagan

📘 Need a book recommendation to start reading this summer season? Learn (almost) all about the role of sinusoidal cells in liver diseases with this one! 25 chapters in 562 pag ✨It looks great in real life, even better with a ☕️! Get yours here (-%): shop.elsevier.com/books/sinusoid…

3⃣Presence and severity of an associated condition, ascites, age, bilirubin, albumin and creatinine are associated with poor prognosis. EASLnews Asociación Española para el Estudio del Hígado Sociedad Española de Patología Digestiva (SEPD) Jose Ignacio (Iñaki) Fortea AngelaPuente Virginia hernandez gea, JC Garcia Pagan

Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome. - Journal of Hepatology journal-of-hepatology.eu/article/S0168-… Proud of this collaborative effort. Thanks to all VALDIG, ERN centers Hospital Clínic IDIBAPS ERN RARE LIVER CIBERehd

1/ 🧵Porto-sinusoidal vascular disorder (#PSVD) is a rare condition. Despite its known hallmarks, much remains unclear, including its pathobiology and the potential for non-invasive testing. Our paper explores PSVD from a metabolomics angle: jhep-reports.eu/article/S2589-…

/4 Together with colleagues from the University of Barcelona Clinical Hospital, we showed the role of taurocholic acid or taurocholic/L-aspartic acid ratio in distinguishing PSVD from healthy and cirrhosis profiles accordingly (AUROC = 0.9 / 0.72) in validation. Img: Fig. 5E